RENEO PHARMACEUTICALS INC (RPHM)
US75974E1038 - Common Stock
| TTM (2024-3-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
| Net Income | -70.70M | -77.39M | -51.96M | -39.77M | -19.47M | |||
| Depreciation Amortization | 146.00K | 170.00K | 90.00K | 50.00K | 40.00K | |||
| Change In Working Capital | -5.85M | 12.22M | 960.00K | -2.80M | 510.00K | |||
| Other non cash items | 763.00K | 1.32M | 3.55M | 4.54M | 380.00K | |||
| OPERATING CASH FLOW | -75.65M | -63.68M | -47.36M | -37.98M | -18.54M | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
| Capital Expenditure | -51.00K | -221.00K | -350.00K | -200.00K | -20.00K | |||
| Other Investing Activity | 5.82M | 10.74M | -57.50M | -23.18M | 7.40M | |||
| INVESTING CASH FLOW | 5.77M | 10.52M | -57.84M | -23.38M | 7.38M | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
| Stock Issued/Repurchased | 59.85M | 60.87M | 470.00K | 132.41M | 47.27M | |||
| FINANCING CASH FLOW | 59.85M | 60.87M | 470.00K | 132.41M | 47.27M | |||
| CHANGE IN CASH | -10.02M | 7.70M | -104.73M | 71.05M | 36.11M | |||
| FREE CASH FLOW | ||||||||
| Operating Cash Flow | -75.65M | -63.68M | -47.36M | -37.98M | -18.54M | |||
| Capital Expenditure | -51.00K | -221.00K | -350.00K | -200.00K | -20.00K | |||
| FREE CASH FLOW | -75.70M | -63.90M | -47.71M | -38.18M | -18.56M | |||
All data in USD